Ra Capital Management, L.P. Connect Biopharma Holdings LTD Transaction History

Ra Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.7 - $2.06 $2.14 Million - $6.31 Million	3,062,871 New	3,062,871 $3.61 Million
Q2 2021 Aug 16, 2021	BUY	$14.16 - $19.53 $56.6 Million - $78.1 Million	3,999,795 Added 133.72%	6,991,003 $137 Million
Q1 2021 May 17, 2021	BUY	$15.9 - $18.61 $47.6 Million - $55.7 Million	2,991,208 New	2,991,208 $55.3 Million

2.98M

Ticker CNTB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,015,800
Market Cap $69.3M
Description
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.